Skinvisible (SKVI) EBITDA Margin (2010 - 2026)
Skinvisible (SKVI) posted EBITDA Margin of -2156.42% for Q2 2026, up 467.06 percentage points from -2623.48% a year earlier and up 262.20 percentage points from the prior quarter.
Powered by 
Analysis
Skinvisible (SKVI) EBITDA Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Skinvisible was -2193.71%, up 700.35 percentage points year-over-year; for FY2025, it came in at -2380.38%, up 465.38 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -2235.17 percentage points (FY2020 to FY2025).
- In prior years, Skinvisible's EBITDA Margin was -2845.76% in FY2024 (-487.74 pp), -2358.02% in FY2023 (-2279.36 pp), -78.66% in FY2022 (-109.71 pp) and 31.05% in FY2021 (+176.27 pp).
- Quarterly EBITDA Margin has run from a low of -3873.86% in Q4 2024 to a high of 60.21% in Q4 2021 over five years.
- On a year-over-year basis, EBITDA Margin has increased in each of the last five quarters, with an average year-over-year change of +145.11 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q3 2021, with a gain of 2730.37 percentage points; the weakest was Q1 2023, with a drop of 2340.25 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -2418.62% (Q1 2026), -2181.02% (Q4 2025) and -2018.78% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | Skinvisible | 864,614.86 | 855,592.86 | 5,000.00 | -2,156.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,156.42% |
| Mar 31, 2026 | -2,418.62% |
| Dec 31, 2025 | -2,181.02% |
| Sep 30, 2025 | -2,018.78% |
| Jun 30, 2025 | -2,623.48% |
| Mar 31, 2025 | -2,698.24% |
| Dec 31, 2024 | -3,617.58% |
| Sep 30, 2024 | -2,124.38% |
| Jun 30, 2024 | -2,505.28% |
| Mar 31, 2024 | -2,116.32% |
| Dec 31, 2023 | -2,379.56% |
| Sep 30, 2023 | -1,915.14% |
| Jun 30, 2023 | -1,906.18% |
| Mar 31, 2023 | 22,346.82% |
| Dec 31, 2022 | 1,045.96% |
| Sep 30, 2022 | 459.83% |
| Jun 30, 2022 | 124.78% |
| Mar 31, 2022 | 150.14% |
| Dec 31, 2021 | 119.64% |
| Sep 30, 2021 | 145.50% |
API Access
Skinvisible EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SKVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SKVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SKVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();